The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma-Reference-Cited by-同舟云学术

The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma

Published:2017-02-15 Issue:15 Volume:8 Page:24932-24948
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Cho Jeong Hyun¹,Lee Hyo-Ji¹,Ko Hyun-Jeong²,Yoon Byung-Il³,Choe Jongseon⁴,Kim Keun-Cheol¹,Hahn Tae-Wook³,Han Jeong A.⁵,Choi Sun Shim⁶,Jung Young Mee⁷,Lee Kee-Ho⁸,Lee Yun-Sil⁹,Jung Yu-Jin¹

Affiliation:

1. Department of Biological Sciences, Kangwon National University, Chuncheon, Republic of Korea

2. College of Pharmacy, Kangwon National University, Chuncheon, Republic of Korea

3. Department of Veterinary Medicine, Kangwon National University, Chuncheon, Republic of Korea

4. Department of Microbiology, School of Medicine, Kangwon National University, Chuncheon, Republic of Korea

5. Department of Biochemistry and Molecular Biology, School of Medicine, Kangwon National University, Chuncheon, Republic of Korea

6. Department of Medical Biotechnology, College of Biomedical Science, Kangwon National University, Chuncheon, Republic of Korea

7. Department of Chemistry, Kangwon National University, Chuncheon, Republic of Korea

8. Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Nowon-gu, Seoul, Republic of Korea

9. Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seodaemun-gu, Seoul, Republic of Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials;Biomedicine & Pharmacotherapy;2024-08

2. Oligoribonucleotides in complexes with D-mannitol alter cell cycle and cause apoptosis in murine melanoma B16 cells;Biopolymers and Cell;2024-06-18

3. Bacillus Calmette-Guérin immunotherapy induces an efficient antitumor response to control murine melanoma depending on MyD88 signaling;Frontiers in Immunology;2024-05-21

4. Harnessing innate immune pathways for therapeutic advancement in cancer;Signal Transduction and Targeted Therapy;2024-03-25

5. Design of a single-center, phase II trial to explore the efficacy and safety of ‘R-ISV-RO’ treatment in advanced tumors;Future Oncology;2024-03-06